. 2022 Sep 21;158(12):1394–1403. doi: 10.1001/jamadermatol.2022.3862

Table 5. Sensitivity Analyses.

Analysis	Week 16 vs baseline			Week 52 vs baseline
Analysis	No.	Mean (95% CI)^a	P value^b	No.	Mean (95% CI)^a	P value^b
Primary analysis	57	−0.02 (−0.08 to 0.05)	.61	38	−0.07 (−0.15 to 0.01)	.09
Baseline TBR >1.6	25	−0.12 (−0.24 to 0.01)	.07	16	−0.21 (−0.35 to −0.08)	.005
PASI score 75	20	−0.09 (−0.24 to 0.05)	.18	12	−0.14 (−0.30 to 0.02)	.07
Treatment adherent^c	23	−0.07 (−0.17 to 0.02)	.14	16	−0.07 (−0.17 to 0.03)	.14

Abbreviations: PASI, Psoriasis Area and Severity Index; TBR, target to background ratio.

^{^a}

The 95% CI is for the difference between the later time vs the earlier time (paired t test).

^{^b}

From paired t test.

^{^c}

Defined as at least 90% adherent with all doses of apremilast.